PT1336605E - Derivados de fenol substituidos ou seus sais como inibidores do factor x de coagulacao - Google Patents
Derivados de fenol substituidos ou seus sais como inibidores do factor x de coagulacaoInfo
- Publication number
- PT1336605E PT1336605E PT01997188T PT01997188T PT1336605E PT 1336605 E PT1336605 E PT 1336605E PT 01997188 T PT01997188 T PT 01997188T PT 01997188 T PT01997188 T PT 01997188T PT 1336605 E PT1336605 E PT 1336605E
- Authority
- PT
- Portugal
- Prior art keywords
- salts
- coagulation factor
- inhibitors
- substituted phenol
- phenol derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
- Fats And Perfumes (AREA)
- Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000356146 | 2000-11-22 | ||
JP2000390321 | 2000-12-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT1336605E true PT1336605E (pt) | 2006-06-30 |
Family
ID=26604464
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT01997188T PT1336605E (pt) | 2000-11-22 | 2001-11-21 | Derivados de fenol substituidos ou seus sais como inibidores do factor x de coagulacao |
Country Status (17)
Country | Link |
---|---|
US (2) | US7504417B2 (pt) |
EP (1) | EP1336605B1 (pt) |
JP (1) | JP3903920B2 (pt) |
KR (1) | KR100863923B1 (pt) |
CN (1) | CN1283626C (pt) |
AT (1) | ATE323071T1 (pt) |
AU (2) | AU2002224064B2 (pt) |
CA (1) | CA2424522C (pt) |
DE (1) | DE60118774T2 (pt) |
DK (1) | DK1336605T3 (pt) |
ES (1) | ES2260336T3 (pt) |
HU (1) | HUP0400558A3 (pt) |
MX (1) | MXPA03003572A (pt) |
PL (1) | PL204898B1 (pt) |
PT (1) | PT1336605E (pt) |
RU (1) | RU2276137C2 (pt) |
WO (1) | WO2002042270A1 (pt) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI290136B (en) | 2000-04-05 | 2007-11-21 | Daiichi Seiyaku Co | Ethylenediamine derivatives |
US7365205B2 (en) | 2001-06-20 | 2008-04-29 | Daiichi Sankyo Company, Limited | Diamine derivatives |
SE0102764D0 (sv) * | 2001-08-17 | 2001-08-17 | Astrazeneca Ab | Compounds |
KR20040096541A (ko) * | 2002-01-31 | 2004-11-16 | 모르포켐 악티엥게셀샤프트 퓌르 콤비나토리셰 케미 | 인자 Xa 활성을 저해하는 화합물 |
GB0226930D0 (en) | 2002-11-19 | 2002-12-24 | Astrazeneca Ab | Chemical compounds |
WO2005080359A1 (en) * | 2004-02-18 | 2005-09-01 | Astrazeneca Ab | Benzamide derivatives and their use as glucokinae activating agents |
BRPI0507734A (pt) * | 2004-02-18 | 2007-07-10 | Astrazeneca Ab | composto ou um sal, pró-droga ou solvato do mesmo, método de tratar doenças mediadas por glk, e, processo para a preparação de um composto |
TW200600086A (en) * | 2004-06-05 | 2006-01-01 | Astrazeneca Ab | Chemical compound |
WO2006040527A1 (en) * | 2004-10-16 | 2006-04-20 | Astrazeneca Ab | Process for making phenoxy benzamide compounds |
GB0423043D0 (en) * | 2004-10-16 | 2004-11-17 | Astrazeneca Ab | Compounds |
JP4900238B2 (ja) | 2005-02-02 | 2012-03-21 | 味の素株式会社 | 新規ベンズアミジン化合物 |
US20110059941A1 (en) * | 2005-05-24 | 2011-03-10 | Peter William Rodney Caulkett | 2-phenyl substituted imidazol [4,5b] pyridine/pyrazine and purine derivatives as glucokinase modulators |
TW200714597A (en) * | 2005-05-27 | 2007-04-16 | Astrazeneca Ab | Chemical compounds |
NZ575514A (en) * | 2005-07-09 | 2009-11-27 | Astrazeneca Ab | Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes |
US20080234273A1 (en) * | 2005-07-09 | 2008-09-25 | Mckerrecher Darren | Heteroaryl Benzamide Derivatives for Use as Glk Activators in the Treatment of Diabetes |
EP1910350A1 (en) * | 2005-07-09 | 2008-04-16 | AstraZeneca AB | 2 -heterocyclyloxybenzoyl amino heterocyclyl compounds as modulators of glucokinase for the treatment of type 2 diabetes |
US9202182B2 (en) * | 2005-08-11 | 2015-12-01 | International Business Machines Corporation | Method and system for analyzing business architecture |
TW200734304A (en) * | 2005-11-08 | 2007-09-16 | Astellas Pharma Inc | Benzene derivative or salt thereof |
TW200738621A (en) | 2005-11-28 | 2007-10-16 | Astrazeneca Ab | Chemical process |
TW200825063A (en) * | 2006-10-23 | 2008-06-16 | Astrazeneca Ab | Chemical compounds |
CL2007003061A1 (es) * | 2006-10-26 | 2008-08-01 | Astrazeneca Ab | Compuestos derivados de 3,5-dioxi-benzamida; proceso de preparacion; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar una enfermedad mediada a traves de glk, tal como la diabetes tipo 2. |
TW200833339A (en) * | 2006-12-21 | 2008-08-16 | Astrazeneca Ab | Novel crystalline compound |
JP2010120852A (ja) * | 2007-03-09 | 2010-06-03 | Daiichi Sankyo Co Ltd | 新規なジアミド誘導体 |
WO2008135524A2 (en) * | 2007-05-02 | 2008-11-13 | Boehringer Ingelheim International Gmbh | Substituted anthranilamides and analogues, manufacturing and use thereof as medicaments |
EP2311810A4 (en) | 2008-07-11 | 2012-04-04 | Ajinomoto Kk | AMIDINE DERIVATIVE |
WO2010015849A2 (en) | 2008-08-04 | 2010-02-11 | Astrazeneca Ab | Therapeutic agents 414 |
TW201021832A (en) * | 2008-09-30 | 2010-06-16 | Astellas Pharma Inc | Pharmaceutical composition for oral administration |
GB0902406D0 (en) * | 2009-02-13 | 2009-04-01 | Astrazeneca Ab | Crystalline polymorphic form |
GB0902434D0 (en) * | 2009-02-13 | 2009-04-01 | Astrazeneca Ab | Chemical process |
AR076221A1 (es) * | 2009-04-09 | 2011-05-26 | Astrazeneca Ab | Derivado de pirazol [4,5-e] pirimidina y su uso para tratar diabetes y obesidad |
AR076220A1 (es) | 2009-04-09 | 2011-05-26 | Astrazeneca Ab | Derivados de pirazol [4,5 - e] pirimidina |
DE102014108210A1 (de) | 2014-06-11 | 2015-12-17 | Dietrich Gulba | Rodentizid |
EP4070658A1 (de) | 2021-04-06 | 2022-10-12 | BIORoxx GmbH | Verwendung von blutgerinnungshemmenden verbindungen als rodentizide |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH04304012A (ja) * | 1991-03-31 | 1992-10-27 | Sony Corp | フイルタ回路 |
US5417200A (en) * | 1994-01-25 | 1995-05-23 | Wasielewski; John J. | Lantern cooker |
JP3004362B2 (ja) * | 1994-12-02 | 2000-01-31 | 山之内製薬株式会社 | 新規なアミジノナフチル誘導体又はその塩 |
AU8270298A (en) * | 1997-06-26 | 1999-01-19 | Eli Lilly And Company | Antithrombotic agents |
WO1999000126A1 (en) | 1997-06-26 | 1999-01-07 | Eli Lilly And Company | Antithrombotic agents |
CA2294042A1 (en) * | 1997-06-26 | 1999-01-07 | David Kent Herron | Antithrombotic agents |
EP1007037A4 (en) | 1997-06-26 | 2004-10-06 | Lilly Co Eli | ANTITHROMBOTIC AGENTS |
US6140351A (en) * | 1997-12-19 | 2000-10-31 | Berlex Laboratories, Inc. | Ortho-anthranilamide derivatives as anti-coagulants |
PL341044A1 (en) * | 1997-12-19 | 2001-03-26 | Schering Ag | Derivatives of orthoantranilic amide as anticoagulants |
WO1999037643A1 (fr) | 1998-01-26 | 1999-07-29 | Yamanouchi Pharmaceutical Co., Ltd. | Nouveaux derives heterocycliques a fusion benzenique ou sels de ceux-ci |
ATE326453T1 (de) * | 1998-12-23 | 2006-06-15 | Lilly Co Eli | Antithrombotische amide |
ES2226485T3 (es) | 1998-12-23 | 2005-03-16 | Eli Lilly And Company | Amidas aromaticas. |
WO2000039117A1 (en) | 1998-12-23 | 2000-07-06 | Eli Lilly And Company | HETEROROAROMATIC AMIDES AS INHIBITOR OF FACTOR Xa |
JP4390024B2 (ja) | 1999-04-23 | 2009-12-24 | アステラス製薬株式会社 | 新規なジアゼパン誘導体又はその塩 |
WO2001019798A2 (en) | 1999-09-17 | 2001-03-22 | Cor Therapeutics Inc. | INHIBITORS OF FACTOR Xa |
MX226123B (es) | 1999-09-17 | 2005-02-07 | Millennium Pharm Inc | Benzamidas e inhibidores del factor xa relacionadas. |
US6632815B2 (en) * | 1999-09-17 | 2003-10-14 | Millennium Pharmaceuticals, Inc. | Inhibitors of factor Xa |
WO2001064643A2 (en) | 2000-02-29 | 2001-09-07 | Cor Therapeutics, Inc. | BENZAMIDES AND RELATED INHIBITORS OF FACTOR Xa |
AU776053B2 (en) | 2000-03-31 | 2004-08-26 | Astellas Pharma Inc. | Diazepan derivatives or salts thereof |
AU2001280438A1 (en) * | 2000-07-27 | 2002-02-13 | Eli Lilly And Company | Substituted heterocyclic amides |
US7163938B2 (en) * | 2000-11-28 | 2007-01-16 | Eli Lilly And Company | Substituted carboxamides |
-
2001
- 2001-11-21 KR KR1020037006813A patent/KR100863923B1/ko not_active IP Right Cessation
- 2001-11-21 PL PL360710A patent/PL204898B1/pl not_active IP Right Cessation
- 2001-11-21 AU AU2002224064A patent/AU2002224064B2/en not_active Ceased
- 2001-11-21 RU RU2003115092/04A patent/RU2276137C2/ru not_active IP Right Cessation
- 2001-11-21 US US10/399,625 patent/US7504417B2/en not_active Expired - Fee Related
- 2001-11-21 AT AT01997188T patent/ATE323071T1/de active
- 2001-11-21 AU AU2406402A patent/AU2406402A/xx active Pending
- 2001-11-21 CN CNB018192564A patent/CN1283626C/zh not_active Expired - Fee Related
- 2001-11-21 MX MXPA03003572A patent/MXPA03003572A/es active IP Right Grant
- 2001-11-21 JP JP2002544406A patent/JP3903920B2/ja not_active Expired - Fee Related
- 2001-11-21 DK DK01997188T patent/DK1336605T3/da active
- 2001-11-21 PT PT01997188T patent/PT1336605E/pt unknown
- 2001-11-21 DE DE60118774T patent/DE60118774T2/de not_active Expired - Lifetime
- 2001-11-21 ES ES01997188T patent/ES2260336T3/es not_active Expired - Lifetime
- 2001-11-21 WO PCT/JP2001/010176 patent/WO2002042270A1/ja active IP Right Grant
- 2001-11-21 EP EP01997188A patent/EP1336605B1/en not_active Expired - Lifetime
- 2001-11-21 CA CA002424522A patent/CA2424522C/en not_active Expired - Fee Related
- 2001-11-21 HU HU0400558A patent/HUP0400558A3/hu unknown
-
2009
- 2009-01-20 US US12/356,376 patent/US7786106B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
KR20030060944A (ko) | 2003-07-16 |
CN1283626C (zh) | 2006-11-08 |
US7504417B2 (en) | 2009-03-17 |
KR100863923B1 (ko) | 2008-10-17 |
ATE323071T1 (de) | 2006-04-15 |
US20040077555A1 (en) | 2004-04-22 |
AU2002224064B2 (en) | 2005-12-08 |
ES2260336T3 (es) | 2006-11-01 |
EP1336605B1 (en) | 2006-04-12 |
JPWO2002042270A1 (ja) | 2004-03-25 |
PL360710A1 (en) | 2004-09-20 |
DE60118774D1 (de) | 2006-05-24 |
DK1336605T3 (da) | 2006-06-19 |
RU2276137C2 (ru) | 2006-05-10 |
CN1476433A (zh) | 2004-02-18 |
PL204898B1 (pl) | 2010-02-26 |
HUP0400558A2 (hu) | 2004-06-28 |
DE60118774T2 (de) | 2007-03-15 |
CA2424522A1 (en) | 2003-03-31 |
EP1336605A1 (en) | 2003-08-20 |
MXPA03003572A (es) | 2003-07-14 |
WO2002042270A1 (fr) | 2002-05-30 |
CA2424522C (en) | 2009-12-29 |
EP1336605A4 (en) | 2004-01-28 |
US20090137498A1 (en) | 2009-05-28 |
JP3903920B2 (ja) | 2007-04-11 |
HUP0400558A3 (en) | 2010-03-29 |
US7786106B2 (en) | 2010-08-31 |
AU2406402A (en) | 2002-06-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT1336605E (pt) | Derivados de fenol substituidos ou seus sais como inibidores do factor x de coagulacao | |
ATE227306T1 (de) | Thrombin-inhibitoren als anticoagulierende mittel | |
ES2120132T3 (es) | Aductos de bisulfito de argininaldehidos utiles como inhibidores de la trombina y anticoagulantes. | |
TR200002965T2 (tr) | Enfeksiyonların terapötik ve profilaktik tedavisi için organofosforlu terkiplerin kullanımı | |
EE05542B1 (et) | Snergilised herbitsiidsed meetodid ja kompositsioonid | |
ATE114113T1 (de) | Verwendung von droloxifen bei der behandlung von knochenerkrankungen. | |
ATE387215T1 (de) | Mittel zur prävention oder behandlung von psoriasis mit einem il-6-antagonist als wirkstoff | |
CY1110894T1 (el) | Μεθοδοι για θεραπεια ή προληψη αγγειακης φλεγμονης χρησιμοποιωντας αναστολεα (-εις) απορροφησης στερολης | |
BR0101264A (pt) | Derivados de diazepan ou seus sais | |
DK0976722T3 (da) | Benzamidin-derivater | |
DK0558529T3 (da) | Farmaceutisk præparat til behandling af forlænget koagulationstid | |
DE60026279D1 (de) | Zusammenstellungen zur prophylaxe und behandlung von allergien des typus i | |
DE60008935D1 (de) | Pyridinsulfonylharnstoffderivate mit herbizider wirkung | |
TR200101841T2 (tr) | Enfeksiyonlardan korunmak ve enfeksiyon tedavisi için bifosfonatların kullanılmaları | |
DE60045638D1 (de) | Vermeidung und behandlung von krankheiten, die mit der blutgerinnung in zusammenhang stehen | |
BR0210033A (pt) | Composição herbicida, e, método para tratar herbicidamente uma planta indesejada | |
ATE344662T1 (de) | Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen | |
PT1362590E (pt) | Utilizacao de cilobradina ou dos seus sais farmaceuticamente aceitaveis para o tratamento ou prevencao de falha cardiaca | |
RS51316B (sr) | Nova upotreba (r)-(-)-2-/5-(4-fluorofenil)-3- piridilmetilaminometil/-hromana i njegovih fiziološki prihvatljivih soli | |
ATE353666T1 (de) | Verwendung von aktiviertem gerinnungsfaktor vii zur behandlung von durch thrombolytische therapie-induzierten wichtigen blutungen | |
DE69905489D1 (de) | Protein c zur behandlung von sichelzellanämie und thalassämie | |
NO995849L (no) | Aldehydfritt desinfeksjonsmiddel for overflater og instrumenter | |
EA200001065A1 (ru) | Применение фосфорорганических соединений для терапевтического и профилактического лечения инфекций | |
AR099165A2 (es) | Un compuesto diaminico, intermediarios para su preparación, su uso para la preparación de un medicamento, medicamento, inhibidor del factor x de coagulación sanguínea activado, anticoagulante, medicamento para prevenir y/o tratar trombosis o embolia y composición medicinal que lo comprenden, procedimiento para la preparación de dicha composición | |
PT1001679E (pt) | Processo para o combate da poa annua em relvados e utilizacao de fenpropimorf como herbicida |